Skip to main content

Advertisement

SpringerLink
Log in

A phase 2 study of weekly high-dose 5-fluorouracil and leucovorin plus biweekly alternating doxorubicin and cisplatin for advanced gastric cancer

  • EDITORIAL
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Department of Hematology/Medical Oncology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA Tel: +1-216-445-6888; Fax: +1-216-444-9464, , , , , , US

    Maurie Markman

Authors
  1. Maurie Markman
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received: 21 January 1998 / Accepted: 19 May 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Markman, M. A phase 2 study of weekly high-dose 5-fluorouracil and leucovorin plus biweekly alternating doxorubicin and cisplatin for advanced gastric cancer. J Cancer Res Clin Oncol 124, 353 (1998). https://doi.org/10.1007/s004320050183

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004320050183

Keywords

Search

Navigation